Dr. Mark Barash, DO

Dr. Barash practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Barash's NPI, 1215355011, was assigned on March 31, 2014. Dr. Barash holds Wisconsin license 64972.

Dr. Barash's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Barash's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Barash is also affiliated with Froedtert Pleasant Prairie Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Barash to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barash practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Barash's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Barash is licensed in Wisconsin.

CMS data shows 371 Medicare services from Dr. Barash across 9 procedure codes in 2024, for 170 Medicare patients. Medicare paid $32,563 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Dr. Barash in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barash's median patient age at 68, with 57% women.

In 2024, Dr. Barash wrote 648 Medicare Part D claims for 107 patients. 46% of them were for generic drugs. CMS names the drug for 582 of them, across 19 drugs with 11 or more claims each, at $904,987 in total drug cost. In 2023, CMS named 305 claims across 11 drugs.

Dr. Barash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barash as offering telehealth.

CMS Open Payments shows 72 general payments to Dr. Barash from 10 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $47,752.